CN1166376C - Powder medicine for treating hepatitis B - Google Patents
Powder medicine for treating hepatitis B Download PDFInfo
- Publication number
- CN1166376C CN1166376C CNB991193261A CN99119326A CN1166376C CN 1166376 C CN1166376 C CN 1166376C CN B991193261 A CNB991193261 A CN B991193261A CN 99119326 A CN99119326 A CN 99119326A CN 1166376 C CN1166376 C CN 1166376C
- Authority
- CN
- China
- Prior art keywords
- gram
- hepatitis
- root
- present
- treating hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine mainly used for treating hepatitis A and hepatitis B, which uses red ant, bupleurum root, dandelion, melon and red sage root as main medicine materials. The present invention mainly uses the principle of soothing livers, expelling blood stasis and eliminating dampness and heat, and the curative ratio for treating hepatitis B can reach above 90%. The present invention has the advantages of low cost, no toxic and side effect, quick curative effect, high curative ratio and no recurrence. Red ant, bupleurum root, dandelion, bitter clove, white clove, trichosanthes kirilowii, astragalus root, white atractylodes rhizome, red sage root and blue vitriol are made into powder.
Description
Technical field
The invention belongs to a kind of medicine for the treatment of hepatitis A, hepatitis B.
Background technology
Treatment hepatitis A, hepatitis B medicine are used at present: the treasured of liver, medicine for treatment of hepatic disease, hepatitis B treating king though these medicines are effective in cure, can not fundamentally obtain taking a turn for the better easily recurrence after the drug withdrawal.The required necessary material of liver can not be replenished, the conversion of adversity of the liver change and hepatocarcinogenesis can't be stoped.
Summary of the invention
The object of the present invention is to provide a kind of hepatitis B, hepatitis A of curing mainly, cure rate can reach the medicine more than 90%.
The present invention be a kind ofly obtain medical treatment from the liver surface, from fact also obtaining medical treatment, and can make liver function produce antibody, all be turned out cloudy from liver function at short notice, be the treatment hepatitis A with week recovery from illness, hepatitis B at recovery from illness in 50 days, severe patient recovery from illness in two months, and can control hepatitis B and transform and cancerate and the possibility of canceration.
The present invention also adopts following principle: be to directly act on liver and obtain the essential material of institute with function of spleen and stomach regulating for liver, regulating functional activities of qi makes liver obtain rehabilitation, based on the soothing the liver stasis of blood of separating, the clearing away heat-damp and promoting diuresis heat-clearing and toxic substances removing is auxilliary, according to plant replenish the essential material of liver function for association's priming directly to liver for making.And the immunologic function of regulating human body, cure rate reaches 95%.Key of the present invention makes takes following composition by weight ratio composition: Paederus densipennis Bernh. 5-10 restrains, Radix Bupleuri 6-12 fills, Herba Taraxaci 6-10 restrains, Pedicellus Melo 2-10 restrains, Faeces Passeris 2-10 restrains, Fructus Trichosanthis 5-10 restrains, Radix Astragali 10-20 restrains, Rhizoma Atractylodis Macrocephalae 10-15 restrains, Radix Salviae Miltiorrhizae 10-30 restrains, Chalcanthitum 0.05-0.5 fills.
Specific implementation method
Compare compatibility by the above component.Wherein Paederus densipennis Bernh. crude drug, Chalcanthitum a little give birth to, surplus medicine oven dry less yellow powder fine flour can use.It is dried that its medicine bubble is that Rhizoma Atractylodis Macrocephalae parched with bran yellowly, Radix Bupleuri, Herba Taraxaci, Pedicellus Melo, Faeces Passeris, Fructus Trichosanthis rise with new watt, and all the other medicines remove impurity, give birth to getting final product.Be that fine powder is processed at a place altogether, make powder.
Claims (1)
1, a kind of medicine for the treatment of hepatitis A, hepatitis B is characterized in that what it was made up of the component of following weight proportioning:
Paederus densipennis Bernh. 5-10 gram, Radix Bupleuri 6-10 gram, Herba Taraxaci 6-10 gram, Pedicellus Melo 2-10 gram, Faeces Passeris 2-10 gram, Fructus Trichosanthis 5-10 gram, Radix Astragali 10-20 gram, Rhizoma Atractylodis Macrocephalae 10-15 gram, Radix Salviae Miltiorrhizae 10-30 gram, Chalcanthitum 0.05-0.5 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991193261A CN1166376C (en) | 1999-09-09 | 1999-09-09 | Powder medicine for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991193261A CN1166376C (en) | 1999-09-09 | 1999-09-09 | Powder medicine for treating hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1248469A CN1248469A (en) | 2000-03-29 |
| CN1166376C true CN1166376C (en) | 2004-09-15 |
Family
ID=5280835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB991193261A Expired - Fee Related CN1166376C (en) | 1999-09-09 | 1999-09-09 | Powder medicine for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1166376C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1311844C (en) * | 2004-10-15 | 2007-04-25 | 田余庆 | Powder of Chinese traditional medicine 'Ganfukang' for treating liver disease |
| CN103948664A (en) * | 2014-04-10 | 2014-07-30 | 任德标 | Medicine capable of treating hepatopathy |
| CN106540146A (en) * | 2015-09-23 | 2017-03-29 | 刘从双 | A kind of Chinese patent medicine for treating hepatopathy |
-
1999
- 1999-09-09 CN CNB991193261A patent/CN1166376C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1248469A (en) | 2000-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101468171B (en) | Medicament for weight-reducing of fat people and weight-gaining of thin people | |
| CN101703730B (en) | Health care wine made of ginseng and the like | |
| CN1334121A (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN101130005A (en) | Traditional Chinese medicine for treating blahs aypnia after hepatocerebral apoplexy | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN101134082A (en) | Traditional Chinese medicine for treating early hemorrhagic apoplexy | |
| CN1436564A (en) | Liver cancer treating medicine and its prepn | |
| CN1319412A (en) | Medicine for treating tachy-arrhythmia | |
| CN1166376C (en) | Powder medicine for treating hepatitis B | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN101234189A (en) | Chinese medicine composition for preventing and treating cardiovascular inflammation (toxin) | |
| CN106539882A (en) | Traditional Chinese medicine composition for foot bath and preparation method thereof | |
| CN105687579A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
| CN101450203A (en) | Oral liquid for treating hemiplegia | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN101167921A (en) | Medicinal composition for treating stomachache and preparation process thereof | |
| CN1086144C (en) | Capsule for tonifying kidney | |
| CN109700976B (en) | Qie and zedoary liver-protecting paste | |
| CN1180550A (en) | Yongquan ointment | |
| CN104958662A (en) | Traditional Chinese medicinal composition for treating fatty liver hepatitis and hyperlipemia and preparation method thereof | |
| CN105998582A (en) | Preparation method of traditional Chinese medicinal composition for treating rheumatoid arthritis | |
| CN1052914C (en) | Suyuwan pill for curing leucoderma | |
| CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
| CN1151872A (en) | Pills for prostate disease | |
| CN1156619A (en) | Capsule for treating pain or numbness and preparing process thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |